Rosuvastatin Tablet, Film Coated
Product Images NDC 71335-2539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71335-2539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
This text presents statistical data on the efficacy of a treatment for a specific condition. The numbers indicate the success rate or impact of the treatment (RSV) versus a control or placebo group. The values represent different variables and measures such as confidence intervals, significance levels, and the number of individuals at risk over a certain period of time. The treatment group RSV is compared against the Placebo group, providing insights into the effectiveness of the intervention.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
This excerpt seems to be presenting a comparison of the effects of Rosuvastatin 20 mg versus placebo on different cardiovascular events in a study involving 8,901 participants. The text shows a breakdown of event rates for various endpoints such as primary end point, cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The hazard ratios and confidence intervals for each endpoint are provided along with p-values indicating statistical significance. The study also includes a note defining cardiovascular death as including fatal myocardial infarction, fatal stroke, sudden death, and other adjudicated causes of cardiovascular death. This information could be useful for evaluating the impact of Rosuvastatin in reducing cardiovascular events in comparison to a placebo.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
FDA Label Image

Label (Lbl713352539)

Label (Lbl713352539)
This text provides information about Rosuvastatin Calcium tablets containing 10 mg of rosuvastatin. It includes a warning to keep the medication out of reach of children, storage instructions, and guidance to scan a QR code for prescribing details. The tablets are repackaged by Bryant Ranch Prepack, Inc. and manufactured by ScieGen Pharmaceuticals. The NDC number is 71335-2539-1.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.